NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Prevision Medicine AG

Prevision Medicine AG

Private
SchlierenHealthcare & Life Scienceshttps://previsionmedicine.com/

Last Round

Grant

Mar 6, 2026

Total Funding Raised

$220,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Prevision Medicine AG is a biotechnology company that provides a functional precision oncology platform to guide personalized cancer treatment decisions.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

precision medicineex vivo drug screeningfunctional precision medicinedrug sensitivity testingtechbiopersonalized oncologycancer diagnosticsdeep morphology learningclinical decision supportsingle-cell analysispatient-derived modelsresearch-use-onlyRUOorganoid screeningai-driven drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prevision Medicine AG Comps

Public and private peers based on sector, stage, and business model.

Prevision Medicine AG comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Prevision Medicine AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 6, 2026
GrantNov 6, 2025
Pre SeedSep 8, 2025
AngelSep 1, 2025

Key People

Founding team and executive leadership

Philip Zimmermann

CEO and Co-Founder

Founding Team

Prevision Medicine AG Investors

Notable investors and investment history

Prevision Medicine AG investors
InvestorRounds
EPFL Innovation ParkGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 8, 2025

    Completed a Pre Seed funding round.

Prevision Medicine AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prevision Medicine AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prevision Medicine AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersSchlieren
Employee Range12
Year Founded2024
Last FundingMar 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.